Severe combined immunodeficiencies (SCID) are a group of rare congenital disorders characterized by the impairment of both humoral and cell-mediated immunity, lymphopenia and low or absent antibody levels. They usually manifest in the first months of life with severe and recurring infections leading to death. Bone marrow transplantation (BMT) needs to be considered as soon as possible after a diagnosis of SCID because these disorders usually run an unpredictable course and may rapidly prove fatal.
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Recombination activating gene-1 (RAG-1) and RAG-2 are the two essential and tissue-specific components for the generation of antigen-binding diversity by assembly of the variable (V), diversity (D), and joining (J) domain exons at the inmunoglobulin and T-cell receptor (TCR) gene loci during lymphocyte development. 3 that result in a functional inability to form antigen receptors through genetic recombination leading to primary inmunodeficiencies in humans. Additionally, patients with SCID secondary to RAG mutations may have Omenn syndrome, characterized by the presence of a substantial number of oligoclonal activated T cells associated with autoreactive manifestations. 4 A 4-month-old child, who had no previous family history of SCID, was referred to our hospital after 3 weeks with prolonged fever episodes, laryngitis, sores in palate, tongue, and anal margin. He presented a low height-weight growth. ADA or PNP deficiencies were not identified, but the immunologic findings were consistent with a T-B-SCID. Immunophenotype analysis showed the following percentages and absolute number of lymphocyte subpopulations: CD3 þ 5.5%-72/ml, CD3 þ CD4 þ 5.3%-70/ml, CD3 þ CD8 þ 0.2%-3/ml, CD19 þ 7.5%-98/ml, and CD16 þ CD56 þ /CD3-87.5%-1149/ml. The serum immunoglobulins were: IgG 62 mg/dl, IgA o2 mg/dl, IgM 11 mg/dl and the proliferative response to several mitogens and anti-CD3 stimulus (stimulus involving TCR) was markedly reduced (except when IL-2 was used as costimulus).
A recombination deficiency was suspected, and the molecular genetic analysis of RAG-1 showed a heterozygous change C1982T in the first base of codon 624, resulting in the conversion of arginine to cysteine (Arg624Cys). 5 The second mutation in RAG-1 gene was not found.
Before BMT, the patient received an appropriate antiinfections therapy, an intestinal decontamination through nonabsorbable antibiotics, oral antifungal drugs, and immunoglobulins administration. The patient underwent an HLA-identical BMT at 7 month from his healthy brother. The BM was unmanipulated and no conditioning regimen was administered. The patient does not present acute or chronic GVHD.
Immunological reconstitution is summarised in Table 1 . Despite T and B lymphopenia, normal lymphoproliferative response to several mitogens were detectable after BMT. Immunoglobulin administration was initiated on day À47 and was stopped on day þ 180, from then onwards, the patient's immunoglobulins values were normal except for the persistent low IgG2 serum level. The child was vaccinated against poliomyelitis, hepatitis B, tetanus, diphtheria, pneumococcal, and Haemophilus influenzae type B capsular polysaccharide 2 years after BMT. Specific antibody production against Haemophilus influenzae type B and pneumococcal capsular polysaccharide were evaluated due to IgG2 subclass deficiency after the immunoglobulin administration was stopped. The results show an impaired specific immunoglobulin production against IgG subclass deficiency is frequently associated with bacterial infections, the most common identified selective antibody deficiency is an impaired response to polysaccharide antigens such as those present in capsule of Streptococcus pneumoniae and Haemophilus influenzae type b. Since IgG2 is the predominant antibody produced in response to some polysaccharide antigens, it is possible that patients with decreased IgG2 levels may have an altered response to infections with encapsulated bacteria, 6 but in our case this has not happened throughout the 7 years clinical evolution without any type of prophylaxis.
We report a 7 years' follow up of a SCID patient due to a RAG-1 defect, who received an allogenic BMT from his HLA-identical brother and maintain T and B lymphopenia and isolated IgG2 deficiency. Despite incomplete immune reconstitution our patient has not had any life-threatening complications (opportunistic or encapsulated bacteria infections), his general condition is good and acute or chronic GVHD has not been observed. 
